DaVita HealthCare Partners Inc (DVA) - Net Assets
Based on the latest financial reports, DaVita HealthCare Partners Inc (DVA) has net assets worth $1.05 Billion USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($17.50 Billion) and total liabilities ($16.45 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check DVA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.05 Billion |
| % of Total Assets | 5.99% |
| Annual Growth Rate | N/A |
| 5-Year Change | -51.14% |
| 10-Year Change | -80.11% |
| Growth Volatility | 63.57 |
DaVita HealthCare Partners Inc - Net Assets Trend (1994–2025)
This chart illustrates how DaVita HealthCare Partners Inc's net assets have evolved over time, based on quarterly financial data. See DVA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for DaVita HealthCare Partners Inc (1994–2025)
The table below shows the annual net assets of DaVita HealthCare Partners Inc from 1994 to 2025. For live valuation and market cap data, see DVA market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $1.16 Billion | -44.61% |
| 2024-12-31 | $2.09 Billion | -23.77% |
| 2023-12-31 | $2.74 Billion | +23.31% |
| 2022-12-31 | $2.22 Billion | -6.17% |
| 2021-12-31 | $2.37 Billion | -18.15% |
| 2020-12-31 | $2.90 Billion | -17.23% |
| 2019-12-31 | $3.50 Billion | -30.47% |
| 2018-12-31 | $5.03 Billion | -14.66% |
| 2017-12-31 | $5.90 Billion | +1.28% |
| 2016-12-31 | $5.82 Billion | -2.11% |
| 2015-12-31 | $5.95 Billion | -3.91% |
| 2014-12-31 | $6.19 Billion | +16.74% |
| 2013-12-31 | $5.30 Billion | +17.61% |
| 2012-12-31 | $4.51 Billion | +98.79% |
| 2011-12-31 | $2.27 Billion | +11.34% |
| 2010-12-31 | $2.04 Billion | -7.16% |
| 2009-12-31 | $2.19 Billion | +3.58% |
| 2008-12-31 | $2.12 Billion | +12.51% |
| 2007-12-31 | $1.88 Billion | +37.60% |
| 2006-12-31 | $1.37 Billion | +45.68% |
| 2005-12-31 | $939.25 Million | +62.97% |
| 2004-12-31 | $576.33 Million | +69.43% |
| 2003-12-31 | $340.16 Million | +252.52% |
| 2002-12-31 | $96.49 Million | -81.60% |
| 2001-12-31 | $524.36 Million | +42.39% |
| 2000-12-31 | $368.24 Million | +5.52% |
| 1999-12-31 | $348.98 Million | -30.92% |
| 1998-12-31 | $505.20 Million | +72.54% |
| 1997-12-31 | $292.80 Million | +24.23% |
| 1996-12-31 | $235.70 Million | +173.75% |
| 1995-12-31 | $86.10 Million | +436.33% |
| 1994-12-31 | $-25.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to DaVita HealthCare Partners Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 28632800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $69.00K | 0.01% |
| Other Comprehensive Income | $-122.78 Million | -10.60% |
| Other Components | $1.61 Billion | 138.94% |
| Total Equity | $1.16 Billion | 100.00% |
DaVita HealthCare Partners Inc Competitors by Market Cap
The table below lists competitors of DaVita HealthCare Partners Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Solventum Corp.
NYSE:SOLV
|
$13.08 Billion |
|
REA Group Ltd
AU:REA
|
$13.09 Billion |
|
Toromont Industries Ltd.
TO:TIH
|
$13.10 Billion |
|
Origin Energy Ltd
AU:ORG
|
$13.10 Billion |
|
SOUTH32 Ltd
AU:S32
|
$13.08 Billion |
|
Huazhu Group Ltd
NASDAQ:HTHT
|
$13.08 Billion |
|
Jinduicheng Molybdenum Co Ltd
SHG:601958
|
$13.08 Billion |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
$13.08 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DaVita HealthCare Partners Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,091,351,000 to 1,158,438,001, a change of -932,912,999 (-44.6%).
- Net income of 746,803,000 contributed positively to equity growth.
- Share repurchases of 1,792,999,000 reduced equity.
- Other comprehensive income increased equity by 188,013,001.
- Other factors decreased equity by 74,730,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $746.80 Million | +64.47% |
| Share Repurchases | $1.79 Billion | -154.78% |
| Other Comprehensive Income | $188.01 Million | +16.23% |
| Other Changes | $-74.73 Million | -6.45% |
| Total Change | $- | -44.61% |
Book Value vs Market Value Analysis
This analysis compares DaVita HealthCare Partners Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 15.81x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1994-12-31 | $-0.42 | $207.91 | x |
| 1995-12-31 | $0.77 | $207.91 | x |
| 1996-12-31 | $1.97 | $207.91 | x |
| 1997-12-31 | $1.89 | $207.91 | x |
| 1998-12-31 | $2.06 | $207.91 | x |
| 1999-12-31 | $1.43 | $207.91 | x |
| 2000-12-31 | $1.48 | $207.91 | x |
| 2001-12-31 | $1.88 | $207.91 | x |
| 2002-12-31 | $0.36 | $207.91 | x |
| 2003-12-31 | $1.50 | $207.91 | x |
| 2004-12-31 | $2.80 | $207.91 | x |
| 2005-12-31 | $4.51 | $207.91 | x |
| 2006-12-31 | $6.47 | $207.91 | x |
| 2007-12-31 | $8.76 | $207.91 | x |
| 2008-12-31 | $10.00 | $207.91 | x |
| 2009-12-31 | $10.53 | $207.91 | x |
| 2010-12-31 | $9.88 | $207.91 | x |
| 2011-12-31 | $11.75 | $207.91 | x |
| 2012-12-31 | $23.01 | $207.91 | x |
| 2013-12-31 | $24.69 | $207.91 | x |
| 2014-12-31 | $28.54 | $207.91 | x |
| 2015-12-31 | $27.51 | $207.91 | x |
| 2016-12-31 | $28.42 | $207.91 | x |
| 2017-12-31 | $30.82 | $207.91 | x |
| 2018-12-31 | $29.20 | $207.91 | x |
| 2019-12-31 | $22.75 | $207.91 | x |
| 2020-12-31 | $23.62 | $207.91 | x |
| 2021-12-31 | $21.56 | $207.91 | x |
| 2022-12-31 | $23.22 | $207.91 | x |
| 2023-12-31 | $29.44 | $207.91 | x |
| 2024-12-31 | $23.96 | $207.91 | x |
| 2025-12-31 | $13.15 | $207.91 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DaVita HealthCare Partners Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 64.47%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.47%
- • Asset Turnover: 0.78x
- • Equity Multiplier: 15.09x
- Recent ROE (64.47%) is above the historical average (23.03%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1994 | 0.00% | 4.95% | 1.28x | 0.00x | $7.46 Million |
| 1995 | 7.08% | 6.80% | 0.55x | 1.90x | $-2.51 Million |
| 1996 | 11.33% | 9.78% | 0.73x | 1.59x | $3.13 Million |
| 1997 | 15.54% | 10.38% | 0.63x | 2.37x | $16.22 Million |
| 1998 | -1.86% | -0.78% | 0.63x | 3.79x | $-59.92 Million |
| 1999 | -42.20% | -10.19% | 0.70x | 5.89x | $-182.15 Million |
| 2000 | 3.66% | 0.91% | 0.93x | 4.34x | $-23.34 Million |
| 2001 | 26.19% | 8.32% | 0.99x | 3.17x | $84.88 Million |
| 2002 | 163.05% | 8.48% | 1.04x | 18.40x | $147.68 Million |
| 2003 | 51.68% | 8.59% | 1.05x | 5.72x | $141.78 Million |
| 2004 | 38.56% | 9.67% | 0.92x | 4.36x | $164.62 Million |
| 2005 | 24.34% | 7.69% | 0.47x | 6.69x | $134.72 Million |
| 2006 | 21.17% | 5.94% | 0.75x | 4.74x | $152.86 Million |
| 2007 | 20.28% | 7.25% | 0.76x | 3.69x | $193.50 Million |
| 2008 | 17.66% | 6.61% | 0.78x | 3.44x | $162.33 Million |
| 2009 | 19.26% | 6.92% | 0.81x | 3.44x | $203.27 Million |
| 2010 | 19.91% | 6.29% | 0.79x | 3.98x | $201.97 Million |
| 2011 | 21.07% | 7.04% | 0.76x | 3.92x | $251.19 Million |
| 2012 | 11.89% | 6.55% | 0.51x | 3.56x | $85.14 Million |
| 2013 | 11.95% | 5.38% | 0.69x | 3.22x | $103.16 Million |
| 2014 | 11.68% | 5.65% | 0.71x | 2.90x | $104.09 Million |
| 2015 | 4.53% | 1.96% | 0.75x | 3.11x | $-325.09 Million |
| 2016 | 15.11% | 5.97% | 0.79x | 3.22x | $297.57 Million |
| 2017 | 11.25% | 6.10% | 0.57x | 3.21x | $73.88 Million |
| 2018 | 3.17% | 1.40% | 0.60x | 3.80x | $-343.91 Million |
| 2019 | 23.17% | 7.12% | 0.66x | 4.95x | $461.02 Million |
| 2020 | 26.71% | 6.70% | 0.68x | 5.86x | $483.96 Million |
| 2021 | 41.27% | 8.42% | 0.68x | 7.22x | $741.35 Million |
| 2022 | 25.19% | 4.83% | 0.69x | 7.61x | $337.92 Million |
| 2023 | 25.21% | 5.70% | 0.72x | 6.16x | $417.20 Million |
| 2024 | 44.77% | 7.31% | 0.74x | 8.27x | $727.21 Million |
| 2025 | 64.47% | 5.47% | 0.78x | 15.09x | $630.96 Million |
Industry Comparison
This section compares DaVita HealthCare Partners Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $533,775,637
- Average return on equity (ROE) among peers: -361.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DaVita HealthCare Partners Inc (DVA) | $1.05 Billion | 0.00% | 15.70x | $13.08 Billion |
| Acadia Healthcare Company Inc (ACHC) | $1.69 Billion | 7.07% | 1.54x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $970.49 Million | 7.58% | 0.46x | $1.69 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $264.44 Million |
| Airsculpt Technologies Inc (AIRS) | $83.99 Million | -5.33% | 1.43x | $348.50 Million |
| Amedisys Inc (AMED) | $810.74 Million | 22.65% | 0.93x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $819.68 Million | 8.62% | 1.87x | $624.22 Million |
| American Shared Hospital Service (AMS) | $15.99 Million | 6.89% | 1.80x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $108.01 Million | -3.68% | 3.35x | $336.36 Million |
| Ardent Health Partners, Inc. (ARDT) | $711.84 Million | -20.09% | 2.86x | $1.28 Billion |
| Astrana Health Inc (ASTH) | $270.37K | -3317.63% | 75.36x | $1.90 Billion |
About DaVita HealthCare Partners Inc
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for di… Read more